转谷氨酰胺酶3通过DC-SIGN激活单核细胞来源树突状细胞促进特应性皮炎皮肤炎症
该研究探讨转谷氨酰胺酶3(TGase3)作为自身变应原在特应性皮炎(AD)中的作用。AD患者血清抗TGase3 IgE显著高于健康人且与疾病严重度正相关,皮损中TGase3表达增加;TGase3经DC-SIGN结合单核细胞来源树突状细胞(MoDCs),诱导IL-6产生和NF-κB活化并促进Th1极化;抑制TGase3可减轻MC903诱导小鼠AD模型的皮肤炎症。
要点
- AD患者血清抗TGase3 IgE显著升高且与疾病严重度正相关
- TGase3经DC-SIGN激活MoDCs产生IL-6并活化NF-κB
- 抑制TGase3可减轻MC903诱导小鼠AD模型皮肤炎症
核心结论
- TGase3是AD的自身变应原并积极参与皮肤炎症,靶向TGase3可能成为治疗AD的策略。
研究设计与样本
- 研究比较AD患者与健康人血清抗TGase3 IgE水平及皮损TGase3表达,并开展体外MoDCs实验和MC903诱导小鼠AD模型实验。
主要发现
- AD患者血清抗TGase3 IgE显著高于健康人,且与疾病严重度正相关。
- AD患者皮损TGase3表达较对照明显增加,Th2细胞因子和/或变应原促进角质形成细胞表达TGase3。
- TGase3经DC-SIGN结合MoDCs,诱导IL-6产生和NF-κB信号通路活化,TGase3处理的MoDCs促进Th1极化。
- 抑制TGase3后MC903诱导AD小鼠模型的皮肤炎症减轻。
临床怎么用
- TGase3及其IgE可作为AD严重度相关标志物进行探索。
- 靶向TGase3可能为AD治疗提供新策略。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Atopic dermatitis (AD) is often concomitant with increased levels of IgE against not only foreign allergens but also autoallergens. AD patients with autoallergy are likely to be more severe and difficult to treat, and self-reactive IgE might be a contributing factor in the pathogenesis of AD. However, how autoallergens are recognized by the immune system and what immune responses are induced subsequently remain largely unknown. We found that the serum level of IgE against transglutaminase 3 (TGase3) was significantly higher in AD patients than in healthy individuals and was positively correlated with disease severity. The expression of TGase3 in the lesional skin of AD patients was markedly increased compared with that of the controls, and Th2 cytokines and/or allergen promoted the expression of TGase3 in keratinocytes. TGase3 bond monocytes-derived dendritic cells (MoDCs) via dendritic cell-specific ICAM-3-grabbing non-integrin (DC-SIGN), which resulted in the production of IL-6 and activation of the NF-κB signaling pathway in MoDCs; and TGase3-treated MoDCs facilitated Th1 polarization. Moreover, skin inflammation in the mouse model of MC903-induced AD was attenuated when TGase3 was inhibited. In conclusion, TGase3 was revealed as an autoallergen in AD and actively involved in skin inflammation; TGase3-targeting might be a therapeutic strategy for the treatment of AD.
引用
- Su H, Luo Y, Sun J, et al. Transglutaminase 3 Promotes Skin Inflammation in Atopic Dermatitis by Activating Monocyte-Derived Dendritic Cells via DC-SIGN. J Invest Dermatol. 2019. PMID: 31425706. doi:10.1016/j.jid.2019.07.703
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。